Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Development of MRI Projection Mapping System for Breast-Conserving Surgery in the Operating Room: Preliminary Clinical Results in Invasive Breast Cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: New York, NY : Hindawi Pub. Co.
    • الموضوع:
    • نبذة مختصرة :
      Aim: To evaluate the feasibility of a newly developed prototype MRI projection mapping (PM) system for localization of invasive breast cancer before breast-conserving surgery.
      Methods: This prospective study enrolled 10 women with invasive breast cancer. MRI was performed in both prone and supine positions. The tumor location was drawn on the breast skin using palpation and sonography while referring to the prone MRI (i.e., a conventional method). A maximum intensity projection image generated from the supine MRI was projected using our PM system, and the tumor location was drawn. The PM system consisted of a projector and a camera and was used to measure the shape of the breast surface using the structured light method. Breast-conserving surgery was performed based on the conventional method. We compared the tumor size and location between the PM and conventional methods or pathology.
      Results: There were no significant differences in the maximum diameters of invasive cancers between the PM system and the conventional method or pathology. The maximum discrepancy in tumor location between the PM and conventional method was 3-8 mm.
      Conclusions: This PM system may support breast-conserving surgery by showing the tumor size and location on the breast surface.
      Competing Interests: Except for Otoichi Nakata MS, the authors declare that they have no conflict of interest. Mr. Nakata is an employee of RICOH.
      (Copyright © 2020 Maki Amano et al.)
    • References:
      Breast Cancer. 2016 Jan;23(1):149-158. (PMID: 24913146)
      Lancet Oncol. 2012 Apr;13(4):412-9. (PMID: 22373563)
      Breast. 2013 Oct;22(5):839-44. (PMID: 23523179)
      Eur Radiol. 2016 Apr;26(4):1064-72. (PMID: 26135000)
      Eur Radiol. 2019 Mar;29(3):1435-1443. (PMID: 30120494)
      J Am Coll Surg. 2014 Aug;219(2):295-302. (PMID: 24880957)
      Med Phys. 2010 Oct;37(10):5421-33. (PMID: 21089778)
      Med Phys. 2013 Apr;40(4):042701. (PMID: 23556922)
      Lancet. 2010 Feb 13;375(9714):563-71. (PMID: 20159292)
      Clin Radiol. 2018 Aug;73(8):700-714. (PMID: 29229179)
      Breast Cancer Res Treat. 2017 Sep;165(2):273-283. (PMID: 28589366)
      Ann Surg Oncol. 2014 Jul;21(7):2203-8. (PMID: 24619494)
      Breast Cancer Res Treat. 2012 Aug;134(3):1179-88. (PMID: 22821400)
      Cancer. 2003 Feb 15;97(4):926-33. (PMID: 12569592)
      Eur J Cancer. 2010 May;46(8):1296-316. (PMID: 20304629)
    • الموضوع:
      Date Created: 20200721 Date Completed: 20210415 Latest Revision: 20220415
    • الموضوع:
      20221213
    • الرقم المعرف:
      PMC7341375
    • الرقم المعرف:
      10.1155/2020/5314120
    • الرقم المعرف:
      32685501